| Type I interferons in the pathogenesis of tuberculosis: molecular drivers and immunological consequences ML Donovan, TE Schultz, TJ Duke, A Blumenthal Frontiers in immunology 8, 1633, 2017 | 105 | 2017 |
| The RP105/MD‐1 complex: molecular signaling mechanisms and pathophysiological implications TE Schultz, A Blumenthal Journal of leukocyte biology 101 (1), 183-192, 2017 | 49 | 2017 |
| RP105 engages phosphatidylinositol 3-kinase p110δ to facilitate the trafficking and secretion of cytokines in macrophages during mycobacterial infection CH Yu, M Micaroni, A Puyskens, TE Schultz, JC Yeo, AC Stanley, ... The Journal of Immunology 195 (8), 3890-3900, 2015 | 28 | 2015 |
| The N‐terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105‐agonistic properties TE Schultz, KH Wiesmüller, M Lucas, KM Dobos, AG Baxter, A Blumenthal Journal of leukocyte biology 103 (2), 311-319, 2018 | 5 | 2018 |
| Characterisation of the molecular mechanisms of RP105-dependent macrophage activation TE Schultz | | 2018 |
| Interference with Wnt pathway improves host control of Listeria monocytogenes in vivo MD Gatica-Andrades, TTK Nguyen, TE Schultz, OJK Wyer, J Melo-Bolivar, ... Immunology 143 (Suppl. 2), 112-112, 2014 | | 2014 |
